Vaccines for preventing influenza in the elderly

Area of Science:

• Gerontology
• Immunology
• Public Health

Background:

• Influenza vaccines are recommended for individuals aged 65+ to reduce complications.
• Vaccination has been a primary strategy for four decades.
• The goal is to protect the most vulnerable elderly population.

Purpose of the Study:

• Assess influenza vaccine effectiveness in preventing illness, hospitalizations, complications, and mortality in the elderly.
• Identify and evaluate comparative studies on influenza vaccines in this age group.
• Document vaccine safety and adverse effects in older adults.

Main Methods:

• Searched multiple databases including CENTRAL, MEDLINE, EMBASE, and Web of Science.
• Included randomized controlled trials (RCTs), quasi-RCTs, cohort, and case-control studies.
• Analyzed outcomes such as influenza, influenza-like illness, hospital admissions, complications, and deaths, stratified by study setting and vaccine type.

Main Results:

• Included 75 studies with 100 data sets.
• Only one underpowered RCT assessed efficacy and effectiveness.
• Low quality of non-RCTs and potential biases limited the ability to draw firm conclusions.

Conclusions:

• The current evidence on influenza vaccine safety, efficacy, and effectiveness in the elderly (65+) is of poor quality.
• Existing data do not provide guidance for vaccination strategies in this demographic.
• A large, adequately powered, publicly-funded randomized, placebo-controlled trial is necessary to resolve current uncertainties.